Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,880.00
(
0.57%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
95.26
(
-0.74%
)
Bitcoin
67,811.97
(
-4.98%
)
News Focus
News Focus

Replies to post #1403 on Outlook Therapeutics Inc (OTLK)

Replies to #1403 on Outlook Therapeutics Inc (OTLK)
icon url

ErnieBilco

05/26/26 9:25 AM

#1476 RE: Stumblebum #1403

5-26-26 Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
icon url

ErnieBilco

05/26/26 9:25 AM

#1477 RE: Stumblebum #1403

Worth the wait - looking forward to breaking a buck for starters